Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients

Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients

We recount a single-center experience with cardiac immunity-related adverse effects in patients treated with immune checkpoint inhibitors. Of 2,830 patients, 9 patients (0.3%) developed cardiac immunity-related adverse effects (4 cases of cardiomyopathies, 2 of myocarditis, 2 of acute pericarditis,...

Full description

Bibliographic Details
Main Authors: Johnny Chahine, MD, Patrick Collier, MD, PhD, Anjli Maroo, MD, W.H. Wilson Tang, MD, Allan L. Klein, MD
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:JACC: Case Reports
Subjects:
cardiotoxicity
immune checkpoint inhibitors
immunity-related adverse events
Online Access:http://www.sciencedirect.com/science/article/pii/S2666084919306916

Internet

http://www.sciencedirect.com/science/article/pii/S2666084919306916

Similar Items